ARTHROPLASTY
Is chemical thromboprophylaxis necessary following total hip replacement?
J Bone Joint Surg Br. 2011 Feb;93(2):251-6255 Japanese patients undergoing primary unilateral cementless total hip replacement (THR) were randomized into three groups to assess the efficacy of current prophylactic treatments for venous thromboembolisims (VTE). This study examined the the use of mechanical prophylactics separately and in conjunction with current pharmacological prophylactics (Fondaparinux and Enoxaparin). The results illustrated that use of mechanical prophylactics separately, as well as in conjunction with pharmacological prophylactics, produced similar results in preventing VTE.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
